Zoetis Equest Pramox
About the product
EQUEST PRAMOX
Moxidectin and Praziquantel oral gel.
Single dose control: cyathostomins, including all larval stages, as well as other nematode species, bots, and all three species of tapeworm.
Longest recommended dosing interval of any routine wormer: 13 weeks.
Licensed to control benzimidazole resistant strains of cyathostomins.
Palatable gel formulation that liquefies in the horse's mouth to reduce risk of rejection to help ensure horses receive their complete dose.
Dial-a-dose syringe with 25kg bodyweight graduations for accurate dosing according to bodyweight.
Licensed for use in horses, ponies and foals from 6 months of age.
EQUEST PRAMOX is a registered trademark of Zoetis UK Ltd. EQUEST PRAMOX contains moxidectin and praziquantel.
Advice on the use of these or alternative treatments must be sought from the medicine prescriber. Further information from Zoetis UK Ltd, Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth, Surrey KT20 7NS
POM-VPS
